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Abstract
Despite their importance, the molecular circuits that control the differentiation of naïve T cells
remain largely unknown. Recent studies that reconstructed regulatory networks in mammalian
cells have focused on short-term responses and relied on perturbation-based approaches that
cannot be readily applied to primary T cells. Here, we combine transcriptional profiling at high
temporal resolution, novel computational algorithms, and innovative nanowire-based tools for
performing perturbations in primary T cells to systematically derive and experimentally validate a
model of the dynamic regulatory network that controls Th17 differentiation. The network consists
of two self-reinforcing, but mutually antagonistic, modules, with 12 novel regulators, whose
coupled action may be essential for maintaining the balance between Th17 and other CD4+ T cell
subsets. Overall, our study identifies and validates 39 regulatory factors, embeds them within a
comprehensive temporal network and reveals its organizational principles, and highlights novel
drug targets for controlling Th17 differentiation.
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Introduction
Effective coordination of the immune system requires careful balancing of distinct pro-
inflammatory and regulatory CD4+ helper T cell populations. Among those, pro-
inflammatory IL-17 producing Th17 cells play a key role in the defense against extracellular
pathogens and have also been implicated in the induction of several autoimmune diseases1.
Th17 differentiation from naïve T-cells can be triggered in vitro by the cytokines TGF-β1
and IL-6. While TGF-β1 alone induces Foxp3+ regulatory T cells (iTreg)2, the presence of
IL-6 inhibits iTreg and induces Th17 differentiation1.
Much remains unknown about the regulatory network that controls Th17 cells3,4.
Developmentally, as TGF-β is required for both Th17 and iTreg differentiation, it is not
understood how balance is achieved between them or how IL-6 biases toward Th17
differentiation1. Functionally, it is unclear how the pro-inflammatory status of Th17 cells is
held in check by the immunosuppressive cytokine IL-103,4. Finally, many of the key
regulators and interactions that drive development of Th17 remain unknown5.
Recent studies have demonstrated the power of coupling systematic profiling with
perturbation for deciphering mammalian regulatory circuits6-9. Most of these studies have
relied upon computational circuit-reconstruction algorithms that assume one ‘fixed’
network. Th17 differentiation, however, spans several days, during which the components
and wiring of the regulatory network likely change. Furthermore, naïve T cells and Th17
cells cannot be transfected effectively in vitro by traditional methods without changing their
phenotype or function, thus limiting the effectiveness of perturbation strategies for inhibiting
gene expression.
Here, we address these limitations by combining transcriptional profiling, novel
computational methods, and nanowire-based siRNA delivery10 (Fig. 1a) to construct and
validate the transcriptional network of Th17 differentiation. The reconstructed model is
organized into two coupled, antagonistic, and densely intra-connected modules, one
promoting and the other suppressing the Th17 program. The model highlights 12 novel
regulators, whose function we further characterized by their effects on global gene
expression, DNA binding profiles, or Th17 differentiation in knockout mice.
Results
A transcriptional time course of Th17 differentiation
We induced the differentiation of naïve CD4+ T-cells into Th17 cells using TGF-β1 and
IL-6, and measured transcriptional profiles using microarrays at eighteen time points along a
72hr time course (Fig. 1, Supplementary Fig. 1a-c, Methods). As controls, we measured
mRNA profiles for cells that were activated without the addition of differentiating cytokines
(Th0). We identified 1,291 genes that were differentially expressed specifically during Th17
differentiation (Methods, Supplementary Table 1) and partitioned them into 20 co-
expression clusters (k-means clustering, Methods, Fig. 1b and Supplementary Fig. 2) with
distinct temporal profiles. We used these clusters to characterize the response and
reconstruct a regulatory network model, as described below (Fig. 2a).
Three main waves of transcription and differentiation
There are three transcriptional phases as the cells transition from a naïve-like state (t=0.5hr)
to Th17 (t=72hr; Fig. 1c and Supplementary Fig. 1c): early (up to 4hr), intermediate
(4-20hr), and late (20-72hr). Each corresponds, respectively, to a differentiation phase5: (1)
induction, (2) onset of phenotype and amplification, and (3) stabilization and IL-23
signaling. The early phase is characterized by transient induction (e.g., Cluster C5, Fig. 1b)
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of immune response pathways (e.g., IL-6 and TGF-β signaling; Fig. 1d and Supplementary
Table 2). Some early induced genes display sustained expression (e.g., Cluster C10, Fig.
1b); these are enriched for transcription factors (TFs), including the key Th17 factors Stat3,
Irf4 and Batf, and the cytokine and cytokine receptors IL-21, Lif, and Il2ra (Supplementary
Table 1). The transition to the intermediate phase (t=4hr) is marked by induction of ROR-γt
(master TF; Supplementary Fig. 1d) and another 12 TFs (Cluster C20, Fig. 1b), both known
(e.g., Ahr) and novel (e.g., Trps1) to Th17 differentiation. During the transition to the late
phase (t=20hr), mRNAs of Th17 signature cytokines are induced (e.g., IL-17a, IL-9; cluster
C19) whereas mRNAs of cytokines that signal other T cell lineages are repressed (e.g., IFN-
γ and IL-4). Regulatory cytokines from the IL-10 family are also induced (IL-10, IL-24),
possibly as a self-limiting mechanism related to the emergence of ‘pathogenic’ or ‘non-
pathogenic’ Th17 cells11. Around 48hr, the cells induce IL23r (data not shown), which plays
an important role in the late phase (Supplementary Fig. 3 Supplementary Table 1).
Inference of dynamic regulatory interactions
We hypothesized that each of the clusters (Fig. 1b, Supplementary Table 2) encompasses
genes that share regulators active in the relevant time points. To predict these regulators, we
assembled a general network of regulator-target associations from published genomics
profiles12-19 (Fig. 2a, Methods). We then connected a regulator to a gene from its set of
putative targets only if there was also a significant overlap between the regulator's putative
targets and that gene's cluster (Methods). Since different regulators act at different times,
the connection between a regulator and its target may be active only within a certain time
window. To determine this window, we labeled each edge with a time stamp denoting when
both the target gene is regulated (based on its expression profile) and the regulator node is
expressed at sufficient levels (based on its mRNA levels and inferred protein levels20;
Methods). In this way, we derived a network ‘snapshot’ for each of the 18 time points (Fig.
2b-d). Overall, 9,159 interactions between 71 regulators and 1,266 genes were inferred in at
least one network.
Substantial regulatory re-wiring during differentiation—The active factors and
interactions change from one network to the next. The vast majority of interactions are
active only at some time window (Fig. 2c), even for regulators (e.g., Batf) that participate in
all networks. Based on similarity in active interactions, we identified three network classes
(Fig. 2c), corresponding to the three differentiation phases (Fig. 2d). We collapsed all
networks in each phase into one model, resulting in three consecutive network models
(Supplementary Fig. 4; Supplementary Table 3). Among the regulators, 33 are active in all
of the networks (e.g. many known master regulators such as Batf1, Irf4, and Stat3), whereas
18 are active in only one (e.g. Stat1 and Irf1 in the early network; ROR-γt in the late
network). Indeed, while ROR-γt mRNA levels are induced at ∼4h, ROR-γt protein levels
increase at approximately 20h and further rise over time, consistent with our model
(Supplementary Fig. 5).
Ranking novel regulators for systematic perturbation—In addition to known Th17
regulators, our network includes dozens of novel factors as predicted regulators (Fig. 2d),
induced target genes, or both (Supplementary Fig. 4; Supplementary Table 3). It also
contains receptor genes as induced targets, both previously known in Th17 cells (e.g.,
IL-1R1, IL-17RA) and novel (e.g., Fas, Itga3).
We ranked candidate regulators for perturbation (Fig. 2a, 3a, Methods), guided by features
that reflect a regulatory role (Fig. 3a, “Network Information”) and a role as target (Fig. 3a,
“Gene Expression Information”). We computationally ordered the genes to emphasize
certain features (e.g., a predicted regulator of key Th17 genes) over others (e.g., differential
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expression in our time course data). We used a similar scheme to rank receptor proteins
(Supplementary Table 4 and Methods). Supporting their quality, our top-ranked factors are
enriched (p<10-3) for manually curated Th17 regulators (Supplementary Fig. 6), and
correlate well (Spearman r>0.86) with a ranking learned by a supervised method (Methods).
We chose 65 genes for perturbation: 52 regulators and 13 receptors (Supplementary Table
4). These included most of the top 44 regulators and top 9 receptors (excluding a few well-
known Th17 genes and/or those for which knockout data already existed), as well as
additional representative lower ranking factors.
Nanowire-based perturbation of primary T cells
In unstimulated primary mouse T cells, viral- or transfection-based siRNA delivery has been
nearly impossible because it either alters differentiation or cell viability21,22. We therefore
used a new delivery technology based on silicon nanowires (NWs)10,23, which we optimized
to effectively (>95%) deliver siRNA into naïve T cells without activating them (Figs. 3b and
c)23.
We attempted to perturb 60 genes with NW-mediated siRNA delivery and achieved efficient
knockdown (<60% transcript remaining at 48hr post activation) for 34 genes (Fig. 3c and
Supplementary Fig. 7). We obtained knockout mice for seven other genes, two of which
(Irf8 and Il17ra) were also in the knockdown set (Supplementary Table 4). Altogether, we
successfully perturbed 39 of the 65 selected genes – 29 regulators and 10 receptors –
including 21 genes not previously associated with Th17 differentiation.
Nanowire-based screen validates 39 regulators in the Th17 network—We
measured the effects of perturbations at 48hr post-activation on the expression of 275
signature genes using the Nanostring nCounter system (Supplementary Tables 5, 6; Il17ra
and Il21r knockouts were also measured at 60hr). The signature genes were computationally
chosen to cover as many aspects of the differentiation process as possible (Methods): they
include most differentially expressed cytokines, TFs, and cell surface molecules, as well as
representatives from each cluster (Fig. 1b), enriched function (Supplementary Table 2), and
predicted targets in each network (Supplementary Table 3). For validation, we profiled a
signature of 86 genes using the Fluidigm BioMark system, obtaining highly reproducible
results (Supplementary Fig. 8).
We scored the statistical significance of a perturbation's effect on a signature gene by
comparing to non-targeting siRNAs and to 18 control genes that were not differentially
expressed (Methods, Fig. 4a, all non-grey entries are significant). Supporting the original
network model (Fig. 2), there is a significant overlap between the genes affected by a
regulator's knockdown and its predicted targets (p ≤ 0.01, permutation test; Supplementary
Methods).
To study the network's dynamics, we measured the effect of 28 of the perturbations at 10hr
(shortly after the induction of ROR-γt; Supplementary Table 5), using the Fluidigm
Biomark system. We found that 30% of the functional interactions are present with the same
activation/repression logic at both 10hr and 48hr, whereas the rest are present only in one
time point (Supplementary Fig. 9). This is consistent with the extent of rewiring in our
original model (Fig. 2b).
Two coupled antagonistic circuits in the Th17 network—Characterizing each
regulator by its effect on Th17 signature genes (e.g. IL17A, IL17F, Fig. 4b, grey nodes,
bottom), we find that at 48hr the network is organized into two antagonistic modules: a
module of 22 ‘Th17 positive factors’ (Fig. 4b, blue nodes: 9 novel) whose perturbation
decreased the expression of Th17 signature genes (Fig. 4b, grey nodes, bottom), and a
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module of 5 ‘Th17 negative factors’ (Fig. 4b, red nodes: 3 novel) whose perturbation did the
opposite. Each of the modules is tightly intra-connected through positive, self-reinforcing
interactions between its members (70% of the intra-module edges), whereas most (88%)
inter-module interactions are negative. This organization, which is statistically significant
(empirical p-value<10-3; Methods, Supplementary Fig. 10), is reminiscent to that observed
previously in genetic circuits in yeast24,25. At 10hrs, the same regulators do not yield this
clear pattern (p>0.5), suggesting that at that point, the network is still malleable.
The two antagonistic modules may play a key role in maintaining the balance between Th17
and other T cell subsets and in self-limiting the pro-inflammatory status of Th17 cells.
Indeed, perturbing Th17 positive factors also induces signature genes of other T cell subsets
(e.g., Gata3, Fig. 4b, grey nodes, top), whereas perturbing Th17 negative factors suppresses
them (e.g., Foxp3, Gata3, Stat4, and Tbx21).
Validation and characterization of novel factors
We now focused on the role of 12 of the positive or negative factors (including 11 of the 12
novel factors that have not been associated with Th17 cells; Fig. 4b, light grey halos). We
used RNA-Seq after perturbing each factor to test whether its predicted targets (Fig. 2) were
affected by perturbation (Fig. 4c, Venn diagram, top). We found highly significant overlaps
(p<10-5) for three of the factors (Egr2, Irf8, and Sp4) that exist in both datasets, and a
border-line significant overlap for the fourth (Smarca4), validating the quality of the edges
in our network.
Next, we assessed the designation of each of the 12 factors as ‘Th17 positive’ or ‘Th17
negative’ by comparing the set of genes that respond to that factor's knockdown (in RNA-
Seq) to each of the 20 clusters (Fig. 1b). Consistent with the original definitions, knockdown
of a ‘Th17 positive’ regulator down-regulated genes in otherwise induced clusters, and up-
regulated genes in otherwise repressed or un-induced clusters (and vice versa for ‘Th17
negative’ regulators; Fig. 4d and Supplementary Fig. 11a,b). The genes affected by either
positive or negative regulators also significantly overlap with those bound by key CD4+
transcription factors (e.g., Foxp326,27, Batf, Irf4, and ROR-γt28,29, Xiao et al., unpublished
data).
Mina promotes the Th17 program and inhibits the Foxp3 program—Knockdown
of Mina, a chromatin regulator from the Jumonji C (JmjC) family, represses the expression
of signature Th17 cytokines and TFs (e.g. ROR-γt, Batf, Irf4) and of late-induced genes
(clusters C9, C19; p<10-5; Supplementary Tables 5 and 7), while increasing the expression
of Foxp3, the master TF of Treg cells. Mina is strongly induced during Th17 differentiation
(cluster C7), is down-regulated in IL23r-/- Th17 cells, and is a predicted target of Batf30,
ROR-γt30, and Myc in our model (Fig. 5a). Mina was shown to suppress Th2 bias by
interacting with the TF NFAT and repressing the IL-4 promoter31. However, in our cells,
Mina knockdown did not induce Th2 genes, suggesting an alternative mode of action via
positive feedback loops between Mina, Batf and ROR-γt (Fig. 5a, left). Consistent with this
model, Mina expression is reduced in Th17 cells from ROR-γt-knockout mice, and the
Mina promoter was found to be bound by ROR-γt by ChIP-Seq (data not shown). Finally,
the genes induced by Mina knockdown significantly overlap with those bound by Foxp3 in
Treg cells26,27 (P<10−25; Supplementary Table 7) and with a cluster previously linked to
Foxp3 activity in Treg cells32 (Supplementary Fig. 11c and Supplementary Table 7).
To further analyze the role of Mina, we measured IL-17a and Foxp3 expression following
differentiation of naïve T cells from Mina-/- mice. Mina-/- cells had decreased IL-17a and
increased Foxp3 compared to wild-type (WT) cells, as detected by intracellular staining
(Fig. 5a). Cytokine analysis of the corresponding supernatants confirmed a decrease in
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IL-17a production and an increase in IFN-γ (Fig. 5a) and TNFα (Supplementary Fig. 12a).
This suggests a model where Mina, induced by ROR-γt and Batf, promotes transcription of
ROR-γt, while suppressing induction of Foxp3, thus affecting the reciprocal Tregs/Th17
balance33 by favoring rapid Th17 differentiation.
Fas promotes the Th17 program and suppresses IFN-γ expression—Fas, the
TNF receptor superfamily member 6, is another Th17 positive regulator (Fig. 5b). Fas is
induced early, and is a target of Stat3 and Batf in our model. Fas knockdown represses the
expression of key Th17 genes (e.g., IL-17a, IL-17f, Hif1a, Irf4, and Rbpj) and of the
induced cluster C14, and promotes the expression of Th1-related genes, including IFN-γ
receptor 1 and Klrd1 (Cd94; by RNA-Seq, Fig. 4, Fig. 5b, Supplementary Table 7 and
Supplementary Fig. 11). Fas and Fas-ligand deficient mice are resistant to the induction of
autoimmune encephalomyelitis (EAE)34, but have no defect in IFN-γ or Th1 responses. The
mechanism underlying this phenomenon was never studied.
To explore this, we differentiated T cells from Fas-/- mice (Fig. 5b, Supplementary Fig. 12c).
Consistent with our knockdown analysis, expression of IL-17a was strongly repressed and
IFN-γ production was strongly increased under both Th17 and Th0 polarizing conditions
(Fig. 5b). These results suggest that besides being a death receptor, Fas may play an
important role in controlling the Th1/Th17 balance, and Fas-/- mice may be resistant to EAE
due to lack of Th17 cells.
Pou2af1 promotes the Th17 program and suppresses IL-2 expression—
Knockdown of Pou2af1 (OBF1) strongly decreases the expression of Th17 signature genes
(Fig. 5c) and of intermediate- and late-induced genes (clusters C19 and C20, p<10-7;
Supplementary Tables 5 and 7), while increasing the expression of regulators of other CD4+
subsets (e.g., Foxp3, Stat4, Gata3) and of genes in non-induced clusters (clusters C2 and
C16 p<10-9; Supplementary Table 5 and 7). Pou2af1's role in T cell differentiation has not
been explored35.
To investigate its effects, we differentiated T cells from Pou2af1-/- mice (Fig. 5c,
Supplementary Fig. 12b). Compared to WT cells, IL-17a production was strongly repressed.
Interestingly, IL-2 production was strongly increased in Pou2af1-/- T cells under non-
polarizing (Th0) conditions. Thus, Pou2af1 may promote Th17 differentiation by blocking
production of IL-2, a known endogenous repressor of Th17 cells36. Pou2af1 acts as a
transcriptional co-activator of the TFs OCT1 or OCT235. IL-17a production was also
strongly repressed in Oct1-deficient cells (Supplementary Fig. 12d), suggesting that Pou2af1
may exert some of its effects through this co-factor.
TSC22d3 may limit Th17 differentiation and pro-inflammatory function—
Knockdown of the TSC22 domain family protein 3 (Tsc22d3) increases the expression of
Th17 cytokines (IL-17a, IL-21) and TFs (ROR-γt, Rbpj, Batf), and reduces Foxp3
expression. Previous studies in macrophages have shown that Tsc22d3 expression is
stimulated by glucocorticoids and IL-10, and it plays a key role in their anti-inflammatory
and immunosuppressive effects37. Tsc22d3 knockdown in Th17 cells increased the
expression of IL-10 and other key genes that enhance its production (Fig. 5d). Although
IL-10 production has been shown33,38,39 to render Th17 cells less pathogenic in
autoimmunity, co-production of IL-10 and IL-17a may be the indicated response for clearing
certain infections like Staphylococcus aureus at mucosal sites40. This suggests a model
where Tsc22d3 is part of a negative feedback loop for the induction of a Th17 cell subtype
that coproduce IL-17 and IL-10 and limits their pro-inflammatory capacity. Tsc22d3 is
induced in other cells in response to the steroid Dexamethasone41, which represses Th17
differentiation and ROR-γt expression42. Thus, Tsc22d3 may mediate this effect of steroids.
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To further characterize Tsc22d3's role, we used ChIP-Seq to measure its DNA-binding
profile in Th17 cells and RNA-Seq following its knockdown to measure its functional
effects. There is a significant overlap between Tsc22d3's functional and physical targets
(P<0.01, e.g., IL-21, Irf4; Methods, Supplementary Table 8). For example, Tsc22d3 binds
in proximity to IL-21 and Irf4, which also become up regulated in the Tsc22d3 knockdown.
Furthermore, the Tsc22d3 binding sites significantly overlap those of major Th17 factors,
including Batf, Stat3, Irf4, and ROR-γt (>5 fold enrichment; Fig. 5d, Supplementary Table
8, and Methods). This suggests a model where Tsc22d3 exerts its Th17-negative function as
a transcriptional repressor that competes with Th17 positive regulators over binding sites,
analogous to previous findings in CD4+ regulation29,43.
Discussion
We combined a high-resolution transcriptional time course, novel methods to reconstruct
regulatory networks, and innovative nanotechnology to perturb T cells, to construct and
validate a network model for Th17 differentiation. The model consists of three consecutive,
densely intra-connected networks, implicates 71 regulators (46 novel), and suggests
substantial rewiring in 3 phases. The 71 regulators significantly overlap with genes
genetically associated with inflammatory bowel disease44 (11 of 71, p<10-9). Building on
this model, we systematically ranked 127 putative regulators (80 novel; Supplementary
Table 4), and tested top ranking ones experimentally.
We found that the Th17 regulators are organized into two tightly coupled, self-reinforcing
but mutually antagonistic modules, whose coordinated action may explain how the balance
between Th17, Treg, and other effector T cell subsets is maintained, and how progressive
directional differentiation of Th17 cells is achieved. Within the two modules are 12 novel
factors (Fig. 4 and 5), which we further characterized, highlighting four of the factors (others
are in Supplementary Note and Supplementary Fig. 13).
In a recent work, Ciofani et al.29 systematically ranked Th17 regulators based on ChIP-Seq
data for known key factors and transcriptional profiles in wild type and knockout cells.
While their network centered on known core Th17 TFs, our complementary approach
perturbed many genes in a physiologically meaningful setting. Reassuringly, their core Th17
network significantly overlaps with our computationally inferred model (Supplementary Fig.
14).
The wiring of the positive and negative modules (Fig. 4 and 5) uncovers some of the
functional logic of the Th17 program, but likely involve both direct and indirect interactions.
Our functional model provides an excellent starting point for deciphering the underlying
physical interactions with DNA binding profiles30 or protein-protein interactions (Wu et
al.45, in this issue of Nature). The regulators we identified are compelling new targets for
regulating the Th17/Tregs balance and for switching pathogenic Th17 into non-pathogenic
ones.
Methods
Mice
C57BL/6 wild-type (wt), Mt−/−, Irf1−/−, Fas-/-, Irf4fl/fl, and Cd4Cre mice were obtained from
Jackson Laboratory (Bar Harbor, ME). Stat1−/− and 129/Sv control mice were purchased
from Taconic (Hudson, NY). IL-12rβ1−/− mice were provided by Dr. Pahan Kalipada from
Rush University Medical Center. IL-17Ra−/− mice were provided by Dr. Jay Kolls from
Louisiana State University/University of Pittsburgh. Irf8fl/fl mice were provided by Dr.
Keiko Ozato from the National Institute of Health. Both Irf4fl/fl and Irf8fl/fl mice were
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crossed to Cd4Cre mice to generate Cd4CrexIrf4fl/fl and Cd4CrexIrf8fl/fl mice. All animals
were housed and maintained in a conventional pathogen-free facility at the Harvard Institute
of Medicine in Boston, MA (IUCAC protocols: 0311-031-14 (VKK) and 0609-058015
(AR)). All experiments were performed in accordance to the guidelines outlined by the
Harvard Medical Area Standing Committee on Animals at the Harvard Medical School
(Boston, MA). In addition, spleens from Mina-/- mice were provided by Dr. Mark Bix from
St. Jude Children's Reseach Hospital (IACUC Protocol: 453). Pou2af1-/- mice were obtained
from the laboratory of Dr. Robert Roeder46. Wild-type and Oct1-/- fetal livers were obtained
at day E12.5 and transplanted into sub-lethally irradiated Rag1-/- mice as previously
described47 (IACUC Protocol: 11-09003).
Cell sorting and in vitro T-cell differentiation in Petri dishes
Cd4+ T cells were purified from spleen and lymph nodes using anti-CD4 microbeads
(Miltenyi Biotech) then stained in PBS with 1% FCS for 20 min at room temperature with
anti-Cd4-PerCP, anti-Cd62l-APC, and anti-Cd44-PE antibodies (all Biolegend, CA). Naïve
Cd4+ Cd62lhigh Cd44low T cells were sorted using the BD FACSAria cell sorter. Sorted cells
were activated with plate bound anti-Cd3 (2μg/ml) and anti-Cd28 (2μg/ml) in the presence
of cytokines. For Th17 differentiation: 2ng/mL rhTGF-β1 (Miltenyi Biotec), 25ng/mL
rmIl-6 (Miltenyi Biotec), 20ng/ml rmIl-23 (Miltenyi Biotec), and 20ng/ml rmIL-β1
(Miltenyi Biotec). Cells were cultured for 0.5 – 72 hours and harvested for RNA,
intracellular cytokine staining, and flow cytometry.
Flow cytometry and intracellular cytokine staining (ICC)
Sorted naïve T cells were stimulated with phorbol 12-myristate 13-aceate (PMA) (50ng/ml,
Sigma-aldrich, MO), ionomycin (1μg/ml, Sigma-aldrich, MO) and a protein transport
inhibitor containing monensin (Golgistop) (BD Biosciences) for four hours prior to detection
by staining with antibodies. Surface markers were stained in PBS with 1% FCS for 20 min
at room temperature, then subsequently the cells were fixed in Cytoperm/Cytofix (BD
Biosciences), permeabilized with Perm/Wash Buffer (BD Biosciences) and stained with
Biolegend conjugated antibodies, i.e. Brilliant Violet 650™ anti-mouse IFN-γ (XMG1.2)
and allophycocyanin–anti-IL-17A (TC11-18H10.1), diluted in Perm/Wash buffer as
described48 (Fig. 5, Supplementary Fig. 11). To measure the time-course of RORγt protein
expression, a phycoerythrin-conjugated anti- Retinoid-Related Orphan Receptor gamma was
used (B2D), also from eBioscience (Supplementary Fig 4). FOXP3 staining for cells from
knockout mice was performed with the FOXP3 staining kit by eBioscience (00-5523-00) in
accordance with their “One-step protocol for intracellular (nuclear) proteins”. Data was
collected using either a FACS Calibur or LSR II (Both BD Biosciences), then analyzed
using Flow Jo software (Treestar)49,50.
Quantification of cytokine secretion using Enzyme-Linked Immunosorbent Assay (ELISA)
Naïve T cells from knockout mice and their wild type controls were cultured as described
above, their supernatants were collected after 72 h, and cytokine concentrations were
determined by ELISA (antibodies for IL-17 and IL-10 from BD Bioscience) or by
cytometric bead array for the indicated cytokines (BD Bioscience), according to the
manufacturers' instructions (Fig. 5, Supplementary Fig. 11).
Microarray data
Naïve T cells were isolated from WT mice, and treated with IL-6 and TGF-β1. Affymetrix
microarrays HT_MG-430A were used to measure the resulting mRNA levels at 18 different
time points (Fig. 1b). Cells treated with IL-6, TGF-β1, and IL-23 were profiled at last four
time points (48 - 72hr). As control, we used time- and culture-matched WT naïve T cells
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stimulated under Th0 conditions. Biological replicates were measured in eight of the
eighteen time points (1hr, 2hr, 10hr, 20hr, 30hr, 42hr, 52hr, 60hr) with high reproducibility
(r2>0.98). For further validation we compared the differentiation time course to published
microarray data of Th17 cells and naïve T cells51 (Supplementary Fig. 1c). In an additional
dataset naïve T cells were isolated from WT and Il23r−/− mice, and treated with IL-6, TGF-
β1 and IL-23 and profiled at four different time points (49hr, 54hr, 65hr, 72hr). Expression
data was preprocessed using the RMA algorithm followed by quantile normalization52.
Detecting differentially expressed genes
Differentially expressed genes (comparing to the Th0 control) were found using four
methods: (1) Fold change. Requiring a 2-fold change (up or down) during at least two time
points. (2) Polynomial fit. We used the EDGE software53,54, designed to identify
differential expression in time course data, with a threshold of q-value≤0.01. (3) Sigmoidal
fit. We used an algorithm similar to EDGE while replacing the polynomials with a sigmoid
function, which is often more adequate for modeling time course gene expression data55.
We used a threshold of q-value≤0.01. (4) ANOVA. Gene expression is modeled by: time
(using only time points for which we have more than one replicate) and treatment (“TGF-
β1+IL-6” or “Th0”). The model takes into account each variable independently, as well as
their interaction. We report cases in which the p-value assigned with the treatment parameter
or the interaction parameter passed an FDR threshold of 0.01.
Overall, we saw substantial overlap between the methods (average of 82% between any pair
of methods). We define the differential expression score of a gene as the number of tests that
detected it. As differentially expressed genes, we report cases with differential expression
score >3.
For the Il23r−/−time course (compared to the WT T cells) we used methods 1–3 (above).
Here we used a fold change cutoff of 1.5, and report genes detected by at least two tests.
Clustering
We considered several ways for grouping the differentially expressed genes, based on their
time course expression data: (1) For each time point, we defined two groups: (a) all the
genes that are over-expressed and (b) all the genes that are under-expressed relative to Th0
cells (see below); (2) For each time point, we defined two groups: (a) all the genes that are
induced and (b) all the genes that are repressed, comparing to the previous time point; (3) K-
means clustering using only the Th17 polarizing conditions. We used the minimal k, such
that the within-cluster similarity (average Pearson correlation with the cluster's centroid)
was higher than 0.75 for all clusters; and, (4) K-means clustering using a concatenation of
the Th0 and Th17 profiles.
For methods (1, 2), to decide whether to include a gene, we considered its original mRNA
expression profiles (Th0, Th17), and their approximations as sigmoidal functions55 (thus
filtering transient fluctuations). We require that the fold change levels (compared to Th0
(method 1) or to the previous time point (method 2)) pass a cutoff defined as the minimum
of the following three values: (1) 1.7; (2) mean + std of the histogram of fold changes across
all time points; or (3) the maximum fold change across all time points. The clusters
presented in Fig. 1b were obtained with method 4. The groupings from methods (1, 2, and 4)
are provided in Supplementary Table 2.
Regulatory network inference
We identified potential regulators of Th17 differentiation by computing overlaps between
their putative targets and sets of differentially expressed genes grouped according to
Yosef et al. Page 9
Nature. Author manuscript; available in PMC 2013 October 25.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
methods 1-4 above. We assembled regulator-target associations from several sources: (1)in
vivo DNA binding profiles (typically measured in other cells) of 298 transcriptional
regulators12-17; (2) transcriptional responses to the knockout of 11 regulatory
proteins 6,43,49,56-60; (3) additional potential interactions obtained by applying the Ontogenet
algorithm (Jojic et al., under review; regulatory model available at: http://www.immgen.org/
ModsRegs/modules.html) to data from the mouse ImmGen consortium (http://
www.immgen.org; January 2010 release19), which includes 484 microarray samples from
159 cell subsets from the innate and adaptive immune system of mice; (4) a statistical
analysis of cis-regulatory element enrichment in promoter regions 18,61; and, (5) the TF
enrichment module of the IPA software (http://www.ingenuity.com/). For every TF in our
database, we computed the statistical significance of the overlap between its putative targets
and each of the groups defined above using a Fisher's exact test. We include cases where p<
5*10-5 and the fold enrichment > 1.5.
Each edge in the regulatory network was assigned a time stamp based on the expression
profiles of its respective regulator and target nodes. For the target node, we considered the
time points at which a gene was either differentially expressed or significantly induced or
repressed with respect to the previous time point (similarly to grouping methods 1 and 2
above). We defined a regulator node as ‘absent’ at a given time point if: (i) it was under
expressed compared to Th0; or (ii) the expression is low (<20% of the maximum value in
time) and the gene was not over-expressed compared to Th0; or, (iii) up to this point in time
the gene was not expressed above a minimal expression value of 100. As an additional
constraint, we estimated protein expression levels using the model from Ref. 20 and using a
sigmoidal fit55 for a continuous representation of the temporal expression profiles, and the
ProtParam software62 for estimating protein half-lives. We require that, in a given time
point, the predicted protein level be no less than 1.7 fold below the maximum value attained
during the time course, and not be less than 1.7 fold below the Th0 levels. The timing
assigned to edges inferred based on a time-point specific grouping (grouping methods 1 and
2 above) was limited to that specific time point. For instance, if an edge was inferred based
on enrichment in the set of genes induced at 1hr (grouping method #2), it will be assigned a
“1hr” time stamp. This same edge could then only have additional time stamps if it was
revealed by additional tests.
Selection of Nanostring signature genes
The selection of the 275-gene signature (Supplementary Table 5, 6) combined several
criteria to reflect as many aspect of the differentiation program as was possible. We defined
the following requirements: (1) the signature must include all of the TFs that belong to a
Th17 microarray signature (comparing to other CD4+ T cells51, see Supplementary
Methods); that are included as regulators in the network and have a differential expression
score>1; or that are strongly differentially expressed (differential expression score=4); (2) it
must include at least 10 representatives from each cluster of genes that have similar
expression profiles (using clustering method (4) above); (3) it must contain at least 5
representatives from the predicted targets of each TF in the different networks; (4) it must
include a minimal number of representatives from each enriched Gene Ontology (GO)
category (computed across all differentially expressed genes); and, (5) it must include a
manually assembled list of ∼100 genes that are related to the differentiation process,
including the differentially expressed cytokines, cytokine receptors and other cell surface
molecules. Since these different criteria might generate substantial overlaps, we used a set-
cover algorithm to find the smallest subset of genes that satisfies all of five conditions. We
added to this list 18 genes whose expression showed no change (in time or between
treatments) in the microarray data.
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The 86-gene signature (used for the Fluidigm BioMark qPCR assay) is a subset of the 275-
gene signature, selected to include all the key regulators and cytokines discussed. We added
to this list 10 control genes (Supplementary Table 5).
Selection of perturbation targets
We used an unbiased approach to rank candidate regulators – transcription factor or
chromatin modifier genes – of Th17 differentiation. Our ranking was based on the following
features: (a) whether the gene encoding the regulator belonged to the Th17 microarray
signature (comparing to other CD4+ T cells51, see Supplementary Methods); (b) whether the
regulator was predicted to target key Th17 molecules (IL-17, lL-21, IL23r, and ROR-γt); (c)
whether the regulator was detected based on both perturbation and physical binding data
from the IPA software (http://www.ingenuity.com/); (d) whether the regulator was included
in the network using a cutoff of at least 10 target genes; (e) whether the gene encoding for
the regulator was significantly induced in the Th17 time course – we only consider cases
where the induction happened after 4 hours to exclude non-specific hits; (f) whether the
gene encoding the regulator was differentially expressed in response to Th17-related
perturbations in previous studies. For this criterion, we assembled a database of
transcriptional effects in perturbed Th17 cells, including: knockouts of Batf56, ROR-γt
(Xiao et al., unpublished), Hif1a57, Stat3 and Stat543,63, Tbx21 (Awasthi et al.,
unpublished), IL23r (this study), and Ahr59. We also included data from the Th17 response
to Digoxin64 and Halofuginone65, as well as information on direct binding by ROR-γt as
inferred from ChIP-seq data (Xiao et al., unpublished). Our analysis of the published
expression data sets is described in the Supplementary Methods. For each regulator, we
counted the number of conditions in which it came up as a significant hit (up/down-
regulated or bound); for regulators with 2 to 3 hits (quantiles 3 to 7 out of 10 bins), we then
assign a score of 1; for regulators with more than 3 hits (quantiles 8-10), we assign a score
of 2 (a score of 0 is assigned otherwise); and, (g) the differential expression score of the
gene in the Th17 time course.
We ordered the regulators lexicographically by the above features according to the order: a,
b, c, d, (sum of e and f), g - that is, first sort according to a then break ties according to b,
and so on. We exclude genes that are not over-expressed during at least one time point. As
an exception, we retained predicted regulators (feature d) that had additional external
validation (feature f). To validate this ranking, we used a supervised test: we manually
annotated 74 regulators that were previously associated with Th17 differentiation. All of the
features are highly specific for these regulators (p<10-3). Moreover, using a supervised
learning method (Naïve Bayes), the features provided good predictive ability for the
annotated regulators (accuracy of 71%, using 5-fold cross validation), and the resulting
ranking was highly correlated with our unsupervised lexicographic ordering (Spearman
correlation > 0.86).
We adapted this strategy for ranking protein receptors. To this end, we excluded feature c
and replaced the remaining “protein-level” features (b and d) with the following definitions:
(b) whether the respective ligand is induced during the Th17 time course; and, (d) whether
the receptor was included as a target in the network using a cutoff of at least 5 targeting
transcriptional regulators.
Gene knockdown using silicon nanowires
4 × 4 mm silicon nanowire (NW) substrates were prepared and coated with 3 μL of a 50 μM
pool of four siGENOME siRNAs (Dharmcon) in 96 well tissue culture plates, as previously
described10. Briefly, 150,000 naïve T cells were seeded on siRNA-laced NWs in 10 μL of
complete media and placed in a cell culture incubator (37°C, 5% CO2) to settle for 45
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minutes before full media addition. These samples were left undisturbed for 24 hours to
allow target transcript knockdown. Afterward, siRNA-transfected T cells were activated
with αCd3/Cd28 dynabeads (Invitrogen), according to the manufacturer's recommendations,
under Th17 polarization conditions (TGF-β1 & IL-6, as above). 10 or 48hr post-activation,
culture media was removed from each well and samples were gently washed with 100 μL of
PBS before being lysed in 20 μL of buffer TCL (Qiagen) supplemented with 2-
mercaptoethanol (1:100 by volume). After mRNA was harvested in Turbocapture plates
(Qiagen) and converted to cDNA using Sensiscript RT enzyme (Qiagen), qRT-PCR was
used to validate both knockdown levels and phenotypic changes relative to 8-12 non-
targeting siRNA control samples, as previously described66. A 60% reduction in target
mRNA was used as the knockdown threshold. In each knockdown experiment, each
individual siRNA pool was run in quadruplicate; each siRNA was tested in at least three
separate experiments (Supplementary Fig. 9).
mRNA measurements in perturbation assays
We used the nCounter system are presented in full in Geiss et al.67 to measure a a custom
CodeSet constructed to detect a total of 293 genes, selected as described above. We also
used the Fluidigm BioMark HD system to measure a smaller set of 96 genes. Finally, we
used RNA-Seq to follow up and validate 12 of the perturbations. Details of the experimental
and analytical procedures of these analyzes are provided in the Supplementary Methods.
Profiling Tsc22d3 DNA binding using ChIP-seq
ChIP-seq for Tsc22d3 was performed as previously described68 using an antibody from
Abcam. The analysis of this data was performed as previously described 7 and is detailed in
the Supplementary Methods.
Estimating statistical significance of monochromatic interactions between modules
The functional network in Fig. 4b consists of two modules: positive and negative. We
compute two indices: (1)within-module index: the percentage of positive edges between
members of the same module (i.e., down-regulation in knockdown/knockout); and, (2)
between-module index: the percentage of negative edges between members of the same
module that are negative. We shuffled the network 1,000 times, while maintaining the nodes'
out degrees (i.e., number of outgoing edges) and edges' signs (positive/negative), and re-
computed the two indices. The reported p-values were computed using a t-test.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Genome wide temporal expression profiles of Th17 differentiation
(a) Overview of approach. (b) Gene expression profiles during Th17 differentiation. Shown
are the differential expression levels for genes (rows) at 18 time points (columns) in Th17
polarizing conditions (TGF-β1 and IL-6; left panel, Z-normalized per row) or Th17
polarizing conditions relative to control activated Th0 cells (right panel, log2(ratio)). The
genes are partitioned into 20 clusters (C1-C20, color bars, right). Right: mean expression (Y
axis) and standard deviation (error bar) at each time point (X axis) for genes in
representative clusters. Cluster size (“n”), enriched functional annotations (“F”), and
representative genes (“M”) are denoted. (c) Three major transcriptional phases. Shown is a
correlation matrix (red: high; blue: low) between every pair of time points. (d)
Transcriptional profiles of key cytokines and cytokine receptors.
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Figure 2. A model of the dynamic regulatory network of Th17 differentiation
(a) Overview of computational analysis. (b) Schematic of temporal network ‘snapshots’.
Shown are three consecutive cartoon networks (top and matrix columns), with three possible
interactions from regulator (A) to targets (B, C & D), shown as edges (top) and matrix rows
(A→B – top row; A→C – middle row; A→D – bottom row). (c) 18 network ‘snapshots’.
Left: each row corresponds to a TF-target interaction that occurs in at least one network;
columns correspond to the network at each time point. A purple entry: interaction is active
in that network. The networks are clustered by similarity of active interactions (dendrogram,
top), forming three temporally consecutive clusters (early, intermediate, late, bottom). Right:
a heatmap denoting edges for selected regulators. (d) Dynamic regulator activity. Shown is,
for each regulator (rows), the number of target genes (normalized by its maximum number
of targets) in each of the 18 networks (columns, left), and in each of the three canonical
networks (middle) obtained by collapsing (arrows). Right: regulators chosen for perturbation
(pink), known Th17 regulators (grey), and the maximal number of target genes across the
three canonical networks (green, ranging from 0 to 250 targets).
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Figure 3. Knockdown screen in Th17 differentiation using silicon nanowires
(a) Unbiased ranking of perturbation candidates. Shown are the genes ordered from left to
right based on their ranking for perturbation (columns, top ranking is leftmost). Two top
matrices: criteria for ranking by ‘Network Information’ (topmost) and ‘Gene Expression
Information’. Purple entry: gene has the feature (intensity proportional to feature strength;
top five features are binary). Bar chart: ranking score. ‘Perturbed’ row: dark grey: genes
successfully perturbed by knockdown followed by high quality mRNA quantification; light
grey: genes we attempted to knockdown but could not achieve or maintain sufficient
knockdown or did not obtain enough replicates; Black: genes we perturbed by knockout or
for which knockout data was already available. Known row: orange entry: a gene was
previously associated with Th17 function (this information was not used to rank the genes;
Supplementary Fig. 6). (b) Scanning electron micrograph of primary T cells (false colored
purple) cultured on vertical silicon nanowires. (c) Effective knockdown by siRNA delivered
on nanowires. Shown is the % of mRNA remaining after knockdown (by qPCR, Y axis:
mean ± standard error relative to non-targeting siRNA control, n = 12, black bar on left) at
48hrs after introduction of polarizing cytokines.
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Figure 4. Coupled and mutually-antagonistic modules in the Th17 network
(a) Impact of perturbed genes on a 275-gene signature. Shown are changes in the expression
of 275 signature genes (rows) following knockdown or knockout (KO) of 39 factors
(columns) at 48hr (as well as IL-21r and IL-17ra KO at 60 hours). Blue: decreased
expression of target following perturbation of a regulator (compared to a non-targeting
control); red: increased expression; Grey: not significant; all color entries are significant
(Methods). ‘Perturbed’ (left): signature genes that are also perturbed as regulators (black
entries). Key signature genes are denoted on right. (b) Two coupled and opposing modules.
Shown is the perturbation network associating the ‘positive regulators’ (blue nodes) of Th17
signature genes, the ‘negative regulators’ (red nodes), Th17 signature genes (grey nodes,
bottom) and signature genes of other CD4+ T cells (grey nodes, top). A blue edge from node
A to B indicates that knockdown of A downregulates B; a red edge indicates that
knockdown of A upregulates B. Light grey halos: regulators not previously associated with
Th17 differentiation. (c) Knockdown effects validate edges in network model. Venn
diagram: we compare the set of targets for a factor in the original model of Fig. 2a (pink
circle) to the set of genes that respond to that factor's knockdown in an RNA-Seq
experiment (yellow circle). Bar chart on bottom: Shown is the -log10(P-value) (Y axis,
hypergeometric test) for the significance of this overlap for four factors (X axis). Similar
results were obtained with a non-parametric rank-sum test (Mann-Whitney U test,
Methods). Red dashed line: P=0.01. (d) Global knockdown effects are consistent across
clusters. Venn diagram: we compare the set of genes that respond to a factor's knockdown in
an RNA-Seq experiment (yellow circle) to each of the 20 clusters of Fig. 1b (purple circle).
We expect the knockdown of a ‘Th17 positive’ regulator to repress genes in induced
clusters, and induce genes in repressed clusters (and vice versa for ‘Th17 negative’
regulators). Heat map: For each regulator knockdown (rows) and each cluster (columns)
shown are the significant overlaps (non grey entries) by the test above. Red: fold enrichment
for up-regulation upon knockdown; Blue: fold enrichment for down regulation upon
knockdown. Orange entries in the top row indicate induced clusters.
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Figure 5. Mina, Fas, Pou2af1, and Tsc22d3 are key novel regulators affecting the Th17
differentiation programs. (a-d, left)
Shown are regulatory network models centered on different pivotal regulators (square
nodes): (a) Mina, (b) Fas, (c) Pou2af1, and (d) Tsc22d3. In each network, shown are the
targets and regulators (round nodes) connected to the pivotal nodes based on perturbation
(red and blue dashed edges), TF binding (black solid edges), or both (red and blue solid
edges). Genes affected by perturbing the pivotal nodes are colored (blue: target is down-
regulated by knockdown of pivotal node; red: target is up-regulated). (a-c, middle and right)
Intracellular staining and cytokine assays by ELISA or Cytometric Bead Assays (CBA) on
culture supernatants at 72h of in vitro differentiated cells from respective KO mice activated
in vitro with anti-CD3 + anti-CD28 with or without Th17 polarizing cytokines (TGF-β +
IL-6). (d, middle) ChIP-Seq of Tsc22d3. Shown is the proportion of overlap in bound genes
(dark grey) or bound regions (light grey) between Tsc22d3 and a host of Th17 canonical
factors (X axis). All results are statistically significant (P<10-6; Methods).
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